Ronald Garb
Forensic Psychiatry · Houston, TXNPI 1891776167
Payments from drug & device makers
Across 806 payments — averaging $19.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$2K
- AbbVie$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Vanda Pharmaceuticals Inc.$823
- Teva Pharmaceuticals USA, Inc.$789
- plus $8K from 31 others
What the payments were for
- Food & beverage$15,17499%
- Education$1981%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few forensic psychiatry providers in Texasto place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 24 | $219,317 |
| CaplytaLumateperone Tosylate | 17 | $27,324 |
| RexultiBrexpiprazole | 15 | $24,666 |
| NuedextaDextromethorphan Hbr/Quinidine | 23 | $21,353 |
| VyvanseLisdexamfetamine Dimesylate | 43 | $18,622 |
| SpravatoEsketamine Hcl | 11 | $18,573 |
| Lisdexamfetamine Dimesylate | 62 | $16,450 |
| TrintellixVortioxetine Hydrobromide | 18 | $15,856 |
| VraylarCariprazine Hcl | 11 | $15,670 |
| ConcertaMethylphenidate Hcl | 24 | $13,854 |
| Vilazodone Hcl | 28 | $7,036 |
| Olanzapine-Fluoxetine HclOlanzapine/Fluoxetine Hcl | 23 | $5,732 |
| Quetiapine Fumarate | 158 | $5,218 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 43 | $4,584 |
| AdderallDextroamphetamine/Amphetamine | 12 | $4,119 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $524 | $219,31724 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse, Trintellix, Adderall | $1,302 | $38,59773 claims |
| Johnson & JohnsonSpravato, Concerta | $717 | $32,42735 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $1,332 | $27,32417 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $1,820 | $24,66615 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $117 | $21,35323 claims |
| AbbVieVraylar | $1,600 | $15,67011 claims |
| Orexo US, Inc.Zubsolv | $62 | $1,93613 claims |
| Almatica Pharma LLCSertraline Hcl | $130 | $58859 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few forensic psychiatry providers in Texason file to place this against a meaningful peer group, so we don't.
Other forensic psychiatry in Houston
- Karen BrownHouston$17K
- Sanjay AdhiaHouston$1K
- Jeffrey DavisHouston$47
- Cynthia RiveraHarlingen$1K
- Maureen BurrowsWest Lake Hills$857
- Shiraj VahoraBig Spring$646
- Matthew FaubionBig Spring$297
- Joseph PennConroe$118
- Eulon TaylorAustin$71
- Maria SweeneySan Antonio$55
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.